Eton Pharmaceuticals Inc

NASDAQ:ETON   3:59:57 PM EDT
7.93
-0.38 (-4.57%)
Products

Eton Pharmaceuticals Inc Says FDA Has Accepted For Filing New Drug Application For Zonisamide Oral Suspension

Published: 10/15/2020 13:04 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Inc - FDA Has Accepted for Filing New Drug Application (nda) for Zonisamide Oral Suspension.
Eton Pharmaceuticals Inc - Application Has Been Assigned a Prescription Drug User Fee Act (pdufa) Date of May 29, 2021.